3rd generation glp 1 agonist How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments

Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Varied Receptor Potency: Achieving Comparable Glycemic and Weight Reduction Effects

29.66

★★★★☆4.8 (126)

GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis

26.89

★★★★★4.9 (98)

Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports

22.60

★★★★★5.0 (157)

The next generation of weight loss medication is here and it is called GLP-3, also known as retatrutide. And if the early research holds up, it might change everything. 👀, Here is why people are so

22.07

★★★★★4.7 (84)

Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports

27.53

★★★★★4.9 (203)

What GLP‑3 Really Is: Retatrutide Triple‑Receptor Drug

29.26

★★★★★5.0 (176)

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy

22.22

★★★★★4.8 (132)